Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of Neurochemistry|March 16, 2007
Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's diseaseFlora Mela, Matteo Marti, Andrzej Dekundy, et al.
Toxicology Letters|October 12, 2004
Ethosuximide and valproate display high efficacy against lindane-induced seizures in miceRafal M Kaminski, Anna M Tochman, Andrzej Dekundy, et al.
Current Medical Research and Opinion|August 13, 2021
Duration and onset of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naïve subjectsDimos D Mitsikostas, Andrzej Dekundy, Angelika Hanschmann, et al.
Journal of Neurology|March 29, 2020
Efficacy and safety of incobotulinumtoxinA in post-stroke upper-limb spasticity in Japanese subjects: results from a randomized, double-blind, placebo-controlled study (J-PURE)Yoshihisa Masakado, Masahiro Abo, Kunitsugu Kondo, et al.
Journal of Neurochemistry|May 30, 2007
Proteomic analysis of striatal proteins in the rat model of L-DOPA-induced dyskinesiaBarbara Valastro, Andrzej Dekundy, Morten Krogh, et al.
Frontiers in Neurology|April 4, 2022
Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Lower Limb Spasticity in Japanese SubjectsYoshihisa Masakado, Hitoshi Kagaya, Kunitsugu Kondo, et al.
Neurobiology of Disease|October 12, 2004
Transcriptome analysis in a rat model of L-DOPA-induced dyskinesiaChristine Konradi, Jenny E Westin, Manolo Carta, et al.
Toxicology and Applied Pharmacology|November 10, 2006
Lithium-methomyl induced seizures in rats: a new model of status epilepticus?Rafal M Kaminski, Piotr Blaszczak, Andrzej Dekundy, et al.
ACS Chemical Neuroscience|April 25, 2013
GluN2A and GluN2B NMDA receptor subunits differentially modulate striatal output pathways and contribute to levodopa-induced abnormal involuntary movements in dyskinetic ratsOmar S Mabrouk, Flora Mela, Mariangela Calcagno, et al.
Neurobiology of Disease|May 11, 2010
A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeysDaniella Rylander, Hanna Iderberg, Qin Li, et al.
Pageof 4